Bimodal onset and pan-cancer uniformity of immune-mediated liver injury: a retrospective cohort study
{{output}}
Background: Immune-mediated liver injury (IMLI) is a critical adverse event in patients treated with PD-1/PD-L1 inhibitors. The study aims to characterize the clinical heterogeneity, temporal dynamics, and immunological drivers o... ...
